Rezolute (RZLT) Cash from Financing Activities (2010 - 2026)

Rezolute (RZLT) reported Cash from Financing Activities of $747000.0 for Q1 2026, up 7370.0% on a YoY basis from $10000.0 in Q1 2025, and up 109.83% sequentially from $356000.0 in Q4 2025.

Rezolute (RZLT) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Rezolute (RZLT) has 16 years of Cash from Financing Activities data on file, last reported at $747000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 7370.0% year-over-year to $747000.0; the trailing twelve-month figure through Mar 2026 stood at $103.2 million (up 48.47% YoY), and the FY2025 full-year result was $107.3 million, up 70.28% from the prior year.
  • Cash from Financing Activities climbed to $747000.0 in Q1 2026, from $356000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $101.2 million in Q2 2025 to a low of -$19000.0 in Q1 2022.
  • A 4-year average of $23.2 million and a median of $829000.0 in 2025 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities tumbled 83.44% in 2025 and surged 7370.0% in 2026, its largest moves.
  • Tracing RZLT's Cash from Financing Activities over 4 years: stood at $11.6 million in 2022, then sank by 94.32% to $657000.0 in 2024, then tumbled by 45.81% to $356000.0 in 2025, then soared by 109.83% to $747000.0 in 2026.
  • Business Quant data shows RZLT's Cash from Financing Activities at $747000.0 in Q1 2026, $356000.0 in Q4 2025, and $911000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 30.14 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 53,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 68.63 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 238.74 Mn
10 Rezolute 518.12 Mn 518.12 Mn - 747,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 747,000.00
Mar 31, 2026 747,000.00
Dec 31, 2025 356,000.00
Dec 31, 2025 356,000.00
Sep 30, 2025 911,000.00
Sep 30, 2025 911,000.00
Jun 30, 2025 101.16 Mn
Jun 30, 2025 101.16 Mn
Mar 31, 2025 10,000.00
Mar 31, 2025 10,000.00
Dec 31, 2024 657,000.00
Dec 31, 2024 657,000.00
Sep 30, 2024 5.50 Mn
Sep 30, 2024 5.50 Mn
Jun 30, 2024 63.33 Mn
Jun 30, 2024 63.33 Mn
Mar 31, 2024 -3,000.00
Mar 31, 2024 -3,000.00
Sep 30, 2022 11.57 Mn
Sep 30, 2022 11.57 Mn